Drug-labels.com

PHL-Levetiracetam: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
250 mg, 500 mg, 750 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - PHL-Levetiracetam

ABOUT THIS MEDICATION

What the medication is used for:

phl-LEVETIRACETAM belongs to the family of medicines called antiepileptics for treating epilepsy. phl-LEVETIRACETAM has been prescribed for you by your doctor to reduce your number of seizures. It is taken with other seizure medications to help control seizures.

What it does:

Levetiracetam is an antiepileptic drug (AED) which is different from existing AEDs. It has antiseizure and antiepileptic activity. The exact mechanism of action is not known, but it appears to be unlike that of commonly used AEDs.

When it should not be used:

You should not use phl-LEVETIRACETAM if you are allergic to any of the ingredients in the product. See what the non-medicinal ingredients are. Contact your doctor immediately if you experience an allergic reaction or any severe or unusual side effects.

What the medicinal ingredient is:

levetiracetam

What the nonmedicinal ingredients are: phl-LEVETIRACETAM Tablets also contain the following inactive ingredients (alphabetically): Colloidal Silicon Dioxide, Corn Starch, Magnesium Stearate, Microcrystalline Cellulose, Povidone, Purified Water, Sodium Starch and Talc.

phl-LEVETIRACETAM 250 mg tablets contain also the following excipients:

FD&C Blue # 2, Hydroxypropyl methylcellulose, Hydroxypropyl methylcellulose, Polyethylene glycol, Polysorbate and Titanium Dioxide.

phl-LEVETIRACETAM 500 mg tablets also contain the following excipients:

Hydroxypropyl methylcellulose, Iron Oxide Black, Iron Oxide Yellow, Polyethylene glycol and Titanium Dioxide.

phl-LEVETIRACETAM 750 mg tablets contain also the following excipients:

Hydroxypropyl methylcellulose, Iron Oxide Red, Polyethylene glycol and Titanium Dioxide.

What dosage forms it comes in:

Tablets: 250 mg, 500 mg and 750 mg

WARNINGS AND PRECAUTIONS

Important points you must tell your doctor before taking phl-LEVETIRACETAM:

C About all your medical conditions, especially if you have any kidney disease.

C If you are pregnant or thinking about becoming pregnant, or if you are breast-feeding. C Any other medicines (prescription and nonprescription) you are taking.

Contract your doctor immediately if you experience any severe, unusual or allergic reactions.

C When taking phl-LEVETIRACETAM, it is very important not to perform any potentially hazardous tasks such as driving a car or operating dangerous machinery until you are sure this medication does not affect your mental alertness or physical coordination C A very small number of people may have thoughts of suicide.

C If you are a female patient taking an oral contraceptive, watch for irregular menstruation or spotting and immediately report such occurrences to your doctor as this may be an indication that the oral contraceptive may not be working properly and you may get pregnant.

INTERACTIONS WITH THIS MEDICATION

Interactions with this medication and other drugs have not generally been observed. However, you should tell your doctor and pharmacist if you are using oral contraceptives and what prescription and non-prescription medications, vitamins, nutritional supplements and herbal products you are taking.

PROPER USE OF THIS MEDICATION

C It is very important that you take phl-

LEVETIRACETAM exactly as your doctor has instructed.

C Never change the dose yourself.

C Do not stop taking it abruptly.

C phl-LEVETIRACETAM tablets are taken

orally twice a day (typically morning and evening). phl-LEVETIRACETAM can be taken with or without food.

C Consult your doctor before taking any other

medicines (prescription or nonprescription).

Missed dose

If you forget to take a dose, take it as soon as you remember, and then go on as usual. However, if it is almost time for your next dose, skip the dose you forgot and go on as usual.

Overdose

Contact your doctor or nearest hospital emergency department, even though you may not feel sick.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most frequently observed side effects are somnolence (sleepiness), asthenia (weakness), infection (such as common cold) and dizziness. Other side effects include: abnormal thinking, amnesia (loss of memory), anxiety, ataxia (lack of coordination), depression, ecchymosis (bruising), emotional lability (mood swings), hostility, nervousness, personality disorder, pharyngitis (sore throat), rhinitis (runny nose), sinusitis (stuffed head), tooth disorders (toothache) and vertigo (sensation of rotation).

SERIOUS SIDE EFFECTS
AND WHAT TO DO ABOUT THEM
Symptom/effect

Talk with your

doctor or pharmacist

Stop

taking

drug and call your doctor or pharmac ist

Only if

severe

In all cases
Extreme sleepiness or tiredness/

Extreme weakness or difficulty

coordinating

muscles normally

/

Mood and

behavior changes such as anxiety, irritability or anger and depression

/

This is not a complete list of side effects. If you have any unexpected effects while taking this drug, contact your doctor or pharmacist.

HOW TO STORE IT

phl-LEVETIRACETAM Tablets should be stored between 15º C and 30º C.

Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

To monitor drug safety, Health Canada collects information on serious and unexpected effects of drugs. If you suspect you have had a serious or unexpected reaction to this drug you may notify Health Canada by:

toll-free telephone: 866-234-2345 toll-free fax: 866-678-6789

By email: cadrmp@hc-sc.gc.ca

By regular mail:

Canadian Adverse Drug Reaction Monitoring Program (CADRMP)

Health Canada

Address Locator: 0701C

Ottawa, ON K1A 0K9

NOTE: Before contacting Health Canada, you should contact your physician or pharmacist.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting Pharmel Inc. at 1-888-550-6060.

Last revised: July 13, 2007.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02297353

Revision date stated in the text: July 13, 2007

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PHL-Levetiracetam

Rx or OTC
Prescription (Rx)?
DIN 02297353, 02297361, 02297388
Schedule(s) PRESCRIPTION
Active ingredient(s) Levetiracetam
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N03 Antiepileptics
      1. N03A Antiepileptics
        1. N03AX Other antiepileptics
          1. N03AX14 Levetiracetam
Company PHARMEL INC
Current status Cancelled Post Market
Strengths and forms
DIN Strength Dosage form(s) Current status
02297353 250 MG Tablet Cancelled Post Market April 16, 2008
02297361 500 MG Tablet Cancelled Post Market April 16, 2008
02297388 750 MG Tablet Cancelled Post Market April 17, 2008

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.